Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
French Health Officials Urge Women to Remove Faulty Breast
Women with a type of French-made breast implant prone to leakage
should have them removed as a safety precaution, French health
officials said Friday.
No increased cancer risk has been detected from rupture of the
devices, which were implanted in thousands of women in Europe, but
leakage can cause inflammation, the French health ministry said in
a statement, the
Wall Street Journal reported. Leakage also makes removal
difficult, the newspaper said.
Women with the implants should have them removed in a "non
urgent manner," the officials advised. Those who decide to keep the
implants should undergo breast scans twice a year, the
"Implant failures" have been reported for about 5 percent of women in France with the devices, made by Poly Implant Prosthese (PIP), according to the Journal. The company went into bankruptcy last year because of the ruptures.
In Britain, where 1 percent of women with PIP implants have
experienced such "failures," health officials said several days ago
they saw no reason to call for routine removal of the devices.
Wal-Mart Pulls Infant Formula From Stores After Newborn's
A batch of Enfamil Newborn powdered infant formula has been
removed from more than 3,000 Wal-Mart stores in the United States
after a newborn who consumed the formula died.
Health officials have not yet determined if the infant's death
is linked to the formula and there is no recall. But Wal-Mart
decided to remove 12.5-ounce cans of the powdered infant formula
with the lot number ZP1K7G from its shelves "out of an abundance of
caution," company spokeswoman Dianna Gee told the
The 10-day-old Missouri boy became seriously ill with a
suspected bacterial infection and died after he was taken off life
support. Samples of the formula consumed by the infant were sent to
the U.S. Centers for Disease Control and Prevention and the Food
and Drug Administration for testing. The manufacturer said tests
showed no traces of the bacteria in the batch before it was
shipped, the news service said.
"At this point it has not been determined whether the illness is linked to the formula or an outside source," Gena Terlizzi, spokeswoman for the Missouri Department of Health and Senior Services, said in a statement, the AP reported.
Motrin Coated Caplets Recalled
Batches of Motrin coated caplets that were distributed in the
United States and a number of other countries have been recalled,
Johnson & Johnson announced Wednesday.
The company said "testing of product samples showed that some
caplets may not dissolve as quickly as intended when nearing their
The pain reliever caplets were distributed in the U.S., Puerto
Rico, Bahamas, Belize, Fiji, Jamaica and St. Lucia.
"This is not a consumer level recall, which means that consumers do not need to dispose of or return the product," according to a news release from J&J's McNeil Consumer Healthcare Division, CNN reported.
"There is no safety concern if consumers continue taking the product in accordance with its label; however, it is possible there may be a delay in experiencing relief," the company said.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.